Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects

Kristoffer Kjærgaard; Anne Catrine Daugaard Mikkelsen; Cecilie Bay-Richter; Anne Landau; Peter Lykke  Eriksen; Betina Elfving; Farzaneh  Tamnaloo; Majken Thomsen; Jeppe Remme Yeoman; Stephen Jacques Hamilton-Dutoit; Hendrik V Arenstorff Vilstrup; Christopher F. Rose; Rajeshwar Mookerjee; Karen Louise Thomsen

Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects

Kristoffer Kjærgaard, Anne Catrine Daugaard Mikkelsen, Cecilie Bay-Richter, Anne Landau, Peter Lykke Eriksen, Betina Elfving, Farzaneh Tamnaloo, Majken Thomsen, Jeppe Remme Yeoman, Stephen Jacques Hamilton-Dutoit, Hendrik V Arenstorff Vilstrup, Christopher F. Rose, Rajeshwar Mookerjee, Karen Louise Thomsen

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

Original language	English
Publication date	28 Sept 2024
Publication status	Published - 28 Sept 2024
Event	ISHEN meeting 2023 - Bad Zwischenahn, Germany Duration: 26 Sept 2023 → 29 Sept 2023

Conference

Conference	ISHEN meeting 2023
Country/Territory	Germany
City	Bad Zwischenahn
Period	26/09/2023 → 29/09/2023

ISHEN meeting 2023
Kjærgaard, K. (Participant)
26 Sept 2023 → 29 Sept 2023
Activity: Participating in or organising an event types › Participation in or organisation af a conference

Cite this

Kjærgaard, K., Mikkelsen, A. C. D., Bay-Richter, C., Landau, A., Eriksen, P. L., Elfving, B., Tamnaloo, F., Thomsen, M., Yeoman, J. R., Hamilton-Dutoit, S. J., Vilstrup, H. V. A., Rose, C. F., Mookerjee, R., & Thomsen, K. L. (2024). Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects. Abstract from ISHEN meeting 2023, Bad Zwischenahn, Germany.

@conference{899bc342c37344a1a9c9121ced669a99,

title = "Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects",

author = "Kristoffer Kj{\ae}rgaard and Mikkelsen, {Anne Catrine Daugaard} and Cecilie Bay-Richter and Anne Landau and Eriksen, {Peter Lykke} and Betina Elfving and Farzaneh Tamnaloo and Majken Thomsen and Yeoman, {Jeppe Remme} and Hamilton-Dutoit, {Stephen Jacques} and Vilstrup, {Hendrik V Arenstorff} and Rose, {Christopher F.} and Rajeshwar Mookerjee and Thomsen, {Karen Louise}",

year = "2024",

month = sep,

day = "28",

language = "English",

note = "ISHEN meeting 2023 ; Conference date: 26-09-2023 Through 29-09-2023",

}

Kjærgaard, K , Mikkelsen, ACD , Bay-Richter, C , Landau, A , Eriksen, PL , Elfving, B, Tamnaloo, F, Thomsen, M, Yeoman, JR, Hamilton-Dutoit, SJ , Vilstrup, HVA, Rose, CF, Mookerjee, R & Thomsen, KL 2024, 'Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects', ISHEN meeting 2023, Bad Zwischenahn, Germany, 26/09/2023 - 29/09/2023.

Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects. / Kjærgaard, Kristoffer ; Mikkelsen, Anne Catrine Daugaard ; Bay-Richter, Cecilie et al.
2024. Abstract from ISHEN meeting 2023, Bad Zwischenahn, Germany.

Research output: Contribution to conference › Conference abstract for conference › Research › peer-review

TY - ABST

T1 - Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects

AU - Kjærgaard, Kristoffer

AU - Mikkelsen, Anne Catrine Daugaard

AU - Bay-Richter, Cecilie

AU - Landau, Anne

AU - Eriksen, Peter Lykke

AU - Elfving, Betina

AU - Tamnaloo, Farzaneh

AU - Thomsen, Majken

AU - Yeoman, Jeppe Remme

AU - Hamilton-Dutoit, Stephen Jacques

AU - Vilstrup, Hendrik V Arenstorff

AU - Rose, Christopher F.

AU - Mookerjee, Rajeshwar

AU - Thomsen, Karen Louise

PY - 2024/9/28

Y1 - 2024/9/28

M3 - Conference abstract for conference

T2 - ISHEN meeting 2023

Y2 - 26 September 2023 through 29 September 2023

ER -

Semaglutide reduces cognitive dysfunction in experimental non-alcoholic steatohepatitis through anti-inflammatory and neuroprotective effects

Conference

Activities

ISHEN meeting 2023

Cite this